
The experts weighed in on a wide variety of psychiatric issues for the first Psychiatric Times issue of 2022.
The experts weighed in on a wide variety of psychiatric issues for the first Psychiatric Times issue of 2022.
Psychiatric Times kicked off 2022 by featuring a wide variety of psychiatric issues and current events throughout January.
How do children with ADHD respond differently to reward and punishment, and how can we help them improve their executive functions?
What are the connections between ADHD, infectious diseases, and COVID-19?
How are minority children with ADHD affected by diagnostic, treatment, and educational inequities—and what can we do about it?
What is the connection between ADHD diagnosis with sexual activity and substance use among college students?
How does an ADHD diagnosis affect the college experience? Recent research allows the students to weigh in.
Patients weigh in on their experiences living with and receiving treatment for the disorder.
Study also suggests link between postpartum depression and insomnia.
How can cognitive behavioral therapy improve outcomes for individuals with insomnia?
Psychiatric Times featured a wide variety of psychiatric issues in this year’s CMEs.
Research identifies common reasons and coping mechanisms for depression that increases during the holidays.
Caplyta is now FDA-approved for depressive episodes from bipolar I and II.
App allows users with serious mental illness to create and share a psychiatric advance directive.
Psychiatric Times, your go-to source for what is relevant and important in the field, is pleased to share the following highlights from the 2021 Neuroscience Education Institute Congress.
Research also shows increased prevalence of social risks and unmet social needs.
Survey respondents cited lack of access to services and therapists as a significant barrier to children’s mental health care.
Adverse effects of solitary confinement and other restrictive housing practices include higher risks of suicide among youth.
It’s been a full week of interesting stories, commentaries, and more on a variety of topics at psychiatrictimes.com.
Award honors the contributions of those who support international medical graduates.
Children and adolescents with ADHD often have low self-esteem. How can magic tricks help?
How can cultural humility in therapeutic settings improve patient outcomes?
What is the connection between inflammation and mood disorders?
How do you manage the 4 most common adverse effects of antipsychotic medications?
Results suggest that psilocybin therapy may prove to be helpful in improving quality of life for patients with cancer.
Larger cities may provide a protective buffer against developing depression.
Research shows potential for increased patient engagement and limited support for improved retention rates.
New Drug Application to be submitted for MDD in late 2022, with separate filing for PPD planned for early 2023.